anti-dementia patch
Scope
Date
~
-
Chemical Industry
Lotte Chemical develops anti-thermal runaway material
Lotte Chemical Corp., South Korea’s second-largest petrochemicals company seeking to ramp up value-added advanced materials production, has de...
Jun 20, 2024 (Gmt+09:00)
-
E-commerce
Coupang fined $102 mn for alleged search algorithm manipulation
Coupang Inc., South Korea’s largest e-commerce platform, was fined 140 billion won ($102 million) on Thursday for allegedly manipulating searc...
Jun 13, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
May 07, 2024 (Gmt+09:00)
-
Steel
Korean steelmakers mull anti-dumping suit vs Chinese, Japanese firms
Under growing pressure from increased imports of cheap Chinese and Japanese steel products, South Korean steelmakers are considering filing an anti-...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Aerospace & Defense
Hanwha wins S.Korean military anti-drone system deals
South Korean aerospace and defense maker Hanwha Systems Co. is set to establish a military system to cope with small unmanned aerial vehicles (UAVs)...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai builds Aegis destroyer with anti-ballistic missiles
ULSAN, South Korea – At the shipyard of HD Hyundai Heavy Industries Co. on Nov. 20 in Ulsan, South Gyeongsang Province, South Korea's ne...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Regulations
Korea’s antitrust body grants conditional OK to Broadcom-VMware deal
South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
The KED View
Five most common frustrations of Korean entrepreneurs
A South Korean company recently gave up on its plan to venture into the burgeoning robot market.Fair-trade regulations that prohibit the creation of...
Oct 12, 2023 (Gmt+09:00)
-
Artificial intelligence
Vuno's brain imaging AI medical device secures FDA certification
South Korea's medical device startup Vuno announced on Tuesday that its AI-powered brain quantification device Vuno Med-DeepBrain has received the 5...
Oct 10, 2023 (Gmt+09:00)
-
Steel
Japanese steelmakers flood South Korea on back of weaker yen
Japanese steelmakers are expanding their market shares in South Korea, backed by the yen's drop against the Korean won to the lowest in eight years....
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio applies for US patent of early diagnosis tech of dementia
South Korean medical diagnostic company NGeneBio Co. announced on Thursday that it has completed the US patent application for its technology relate...
Sep 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio to sell dementia drug AR1001 in China with partner
South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
S.Korean food company hy boosts cosmetics unit
South Korea’s hy, formerly Korea Yakult, has launched cosmetics made with fermented products using its self-developed lactic acid bacteria, ex...
Sep 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 participates in drone road show in Riyadh
South Korean leading defense company LIG Nex1 Co. took part in a drone-focused workshop "2023 Korea-Saudi Arabia Drone Road Show" in Riyadh, Saudi A...
Aug 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
Aug 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Raphas microneedle passes US FDA's cGMP inspection
South Korea's microneedle maker Raphas Co. announced on Wednesday that it has passed the Current Good Manufacturing Practice (cGMP) inspection by ...
Jul 26, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia completes flying drone interception test
Hyundai Wia Corp., an auto parts and defense unit of Hyundai Motor Group, announced on Thursday that the first shooting trial of its anti-drone syst...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SCM Lifescience kicks off anti-hair loss product exports to SE Asia
South Korea’s stem cell tech company SCM Lifescience on Wednesday said it has started full-scale exports to Southeast Asia of its hair loss ca...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)